New strategy aims to stop prostate cancer before it turns deadly
NCT ID NCT03258320
Summary
This study is testing if giving strong chemotherapy drugs before surgery can better control aggressive prostate cancer in men. The goal is to shrink the tumor and prevent it from becoming a harder-to-treat, resistant form of the disease. About 300 men with high-risk prostate cancer that hasn't spread will receive one of four chemotherapy drugs followed by surgery to remove the prostate.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER PATIENTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Qilu Hospital of Shandong University
RECRUITINGQingdao, Shandong, 266035, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Zhongshan Hospital
RECRUITINGShanghai, 200032, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.